Philippe Jaffré
Directeur Financier/CFO chez Inflectis Bioscience SAS
Profil
Philippe Jaffré is currently the Chief Financial Officer at Inflectis Bioscience SAS.
Previously, he worked as the Finance Director-Blood Testing Division at Chiron Corp., Principal at Dana Corp., Principal at Novartis Nutrition SAS, Chief Financial Officer at Tc Land Expression SA, Head-Business Planning & Analysis at Novartis Pharmaceuticals, and Principal at Dana Capital Group, Inc. Jaffré holds an MBA from The Pennsylvania State University and an undergraduate degree from the University of Nice Sophia Antipolis.
Postes actifs de Philippe Jaffré
| Sociétés | Poste | Début |
|---|---|---|
Inflectis Bioscience SAS
 Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Directeur Financier/CFO | - |
Anciens postes connus de Philippe Jaffré
| Sociétés | Poste | Fin |
|---|---|---|
| Dana Corp. | Corporate Officer/Principal | - |
| Dana Capital Group, Inc. | Corporate Officer/Principal | - |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Corporate Officer/Principal | - |
Novartis Nutrition SAS
 Novartis Nutrition SAS Pharmaceuticals: MajorHealth Technology Part of Fresenius SE & Co. KGaA, Novartis Nutrition SAS is a French company that manufactures nutrition and medical devices for enteral feeding. The company is based in Revel, France. | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Formation de Philippe Jaffré
| University of Nice Sophia Antipolis | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Tc Land Expression SA
 Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Commercial Services |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Novartis Nutrition SAS
Novartis Nutrition SAS Pharmaceuticals: MajorHealth Technology Part of Fresenius SE & Co. KGaA, Novartis Nutrition SAS is a French company that manufactures nutrition and medical devices for enteral feeding. The company is based in Revel, France. | Health Technology |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
| Dana Capital Group, Inc. | |
| Dana Corp. | Producer Manufacturing |
Inflectis Bioscience SAS
Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Health Technology |